Clinical Trial Update: Crossover Study With MultiHance vs a Comparator for Peripheral MRA [Phase 3]

View source ↗

Summary

Phase 3 crossover trial comparing MultiHance (gadobenate dimeglumine) with a comparator for peripheral MR angiography in peripheral vascular disease. The study …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peripheral Vascular Disease

Drugs mentioned

• MULTIHANCE (Gadobenate dimeglumine)

Snippet

Sponsor: Bracco Diagnostics, Inc | Conditions: Peripheral Vascular Disease | Phase 3 | Status: COMPLETED